TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BMEA

Biomea Fusion Inc

Healthcare · Biotechnology

0.6599$ +3.2% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns Biomea Fusion Inc (BMEA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.6% of the shares are freely tradable; institutional investors hold 38.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 38.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 93.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 23.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 72Mio.

Largest Shareholders

Institutions

Institutions BMEA
Name Stake (%) Shares Change (%) Date
FMR Inc 12.16 8,814,946 +0.0 06/30/2026
Vanguard Capital Management, LLC 3.90 2,829,927 +9.0 06/30/2026
Marshall Wace Asset Management Ltd 2.83 2,049,802 +71.0 06/30/2026
Aisling Capital Management LP 2.83 2,048,757 +0.0 06/30/2026
Renaissance Technologies Corp 2.01 1,455,474 +10.9 06/30/2026
Fideuram - Intesa Sanpaolo Private Banking Spa 1.00 723,176 +29.8 06/30/2026

Funds

Funds BMEA
Name Stake (%) Shares Change (%) Date
Fidelity Growth Company Fund 3.74 2,708,445 +0.0 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.93 2,122,086 +0.0 09/30/2026
Fidelity Growth Company K6 1.26 910,495 +0.0 08/31/2026
Fidelity Series Growth Company 1.11 804,702 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?